INTRODUCTION
Angioplasty and stent implantation are often used in the treatment of peripheral arterial occlusive disease (PAOD). Risk factors that limit stent patency have been extensively evaluated. Nitinol alloys, the most commonly used as a self-expanding stent material, provide increased flexibility and radial force that allow the stent to adapt to the vessel shape. However, specific stresses and physiological environments can lead to stent fracture [1] . Stent fracture is a risk factor for stent occlusion though it is usually asymptomatic. The authors experienced 2 cases of stent fracture among 40 cases of superficial femoral artery (SFA) stenting for 14 months. Here, we report on 2 cases of stent fractures and include a pertinent literature review.
CASE REPORTS Case 1
A 75-year-old man presented with recurrence of short distance claudication in the left leg. The patient had hypertension and a previous history of femoropopliteal bypass due to PAOD on his right SFA. Fourteen months ago, the patient underwent primary stenting of the left SFA to treat total occlusion with two overlapping self-expanding stents thesurgery.or.kr (Smart, Cordis, Miami, FL, USA). The stent deployed in the distal SFA was 7 mm in diameter and 15 cm in length, and the stent deployed in the proximal SFA was 7 mm in diameter and 12 cm in length with an overlap of 2 to 3 cm.
Roentgenogram of stents showed complete transverse linear fracture with partial displacement in Hunter's canal distal to the stent overlap area (Fig. 1) . Subsequent angiography revealed recurrent occlusion of the stented site ( Fig.   2 ). Femoropopliteal artery bypass with reversed great saphenous vein was done resulting in the resolution of the claudication (Fig. 3) .
Case 2
A 72-year-old man with hypertension and ischemic coronary artery disease presented with recurrence of 500 m claudication in both legs. Four months ago, the patient underwent primary stenting for chronic total occlusion of SFA due to symptoms of the 500 m claudication. Two self- expanding nitinol stents (Smart, Cordis) were implanted.
The distal stent was 7 mm in diameter and 15 cm in length, and the proximal stent was 7 mm in diameter and 12 cm in length with 2 cm of overlap in mid SFA. Roentgenogram revealed 3 strut fractures without displacement in the mid-SFA portion (Fig. 4) , and subsequent angiography revealed multiple in-stent restenosis as well as stent fracture sites (Fig. 5) . The narrowed portion of the stented site was dilated with a 6 mm balloon and a 7 × 60 mm stent was inserted at the site of stent fractures (Fig. 6) . Angiographic results were satisfactory with symptom resolution.
DISCUSSION
Revascularization with nitinol stent implantation has better long-term results than angioplasty alone [2] ; however, the cumulative incidence of femoropopliteal stent fracture varies from 2 to 65% in several studies looking specifically for stent fractures [3] . Stent fractures can be Furthermore, atherosclerosis usually involves long segments of the SFA. Scheinert et al. [4] reported that stent fracture incidence increases with stent length, with the fracture rate being significantly lower in segments less than 8 cm. Procedural choice such as use of overlapping stents has a role in stent fracture. Stent overlapping also makes the stent susceptible to fracture. The overlapped segment may act as fulcrum for stent fracture by focusing the stress on a specific stent site [5] . Structural characteristics of the stent also contribute to stent fracture when implanted in a specific setting. Nitinol stents, the most commonly used self-expanding stents, have great biocompatibility, elasticity and shape-memory properties; however their super-elasticity limits the stiffness of the stented vessel creating a hinge point predisposing to stent fracture [6] . In conclusion, femoral artery stenting is a common treatment for PAOD. However, stent fracture is one of the factors limiting long-term patency. We experienced two cases of stent fractures and recognized that a stent surveillance program is important for early detection and treatment before stent occlusion.
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